| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/2007 | EP1827443A1 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 09/05/2007 | EP1827442A1 Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions |
| 09/05/2007 | EP1827441A1 Combinations for the treatment of diseases involving cell proliferation |
| 09/05/2007 | EP1827440A1 Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| 09/05/2007 | EP1827439A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/05/2007 | EP1827438A2 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 09/05/2007 | EP1827437A2 Combinations of therapeutic agents for treating cancer |
| 09/05/2007 | EP1827436A2 Inhibitors of akt activity |
| 09/05/2007 | EP1827435A2 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 09/05/2007 | EP1827434A2 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 09/05/2007 | EP1827433A1 A composition comprising at least 3 different diols |
| 09/05/2007 | EP1827432A1 Inhalation medicament containing a novel anticholinesterase drug, formoterol and a steroid |
| 09/05/2007 | EP1827431A1 Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury |
| 09/05/2007 | EP1827430A1 Nanoparticulate benzothiophene formulations |
| 09/05/2007 | EP1827429A2 Pharmaceutical compositions comprising amorphous benzimidazole compounds |
| 09/05/2007 | EP1827428A1 Compositions comprising an epothilone and production methods |
| 09/05/2007 | EP1827427A1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 09/05/2007 | EP1827426A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 09/05/2007 | EP1827425A1 Use of ppar agonists for the treatment of congestive heart failure |
| 09/05/2007 | EP1827424A1 Combination therapy comprising telmisartan and hydrochlorothiazide |
| 09/05/2007 | EP1827423A1 Novel cyclic ureas used as inhibitors of metalloproteases |
| 09/05/2007 | EP1827422A2 Jnk inhibitors for the treatment of cns injury |
| 09/05/2007 | EP1827420A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 09/05/2007 | EP1827419A2 Methods and compositions for enhancing iron absorption |
| 09/05/2007 | EP1827418A2 Compositions including iron |
| 09/05/2007 | EP1827417A1 Enhanced occlusive effect photodynamic therapy |
| 09/05/2007 | EP1827416A1 Pharmaceutical compositions |
| 09/05/2007 | EP1827415A1 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 09/05/2007 | EP1827414A1 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients |
| 09/05/2007 | EP1827413A1 Use of cyclodextrin complexes containing lipoic acid |
| 09/05/2007 | EP1827412A1 Compositions for use in surgery |
| 09/05/2007 | EP1827411A2 Diphenylurea derivatives useful as potassium channel activators |
| 09/05/2007 | EP1827410A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 09/05/2007 | EP1827409A2 Rasagiline orally disintegrating compositions |
| 09/05/2007 | EP1827408A1 Method for treating skin disorders with xanthophylls |
| 09/05/2007 | EP1827407A2 Methods, assays and compositions for treating retinol-related diseases |
| 09/05/2007 | EP1827406A1 Anti-radical agents |
| 09/05/2007 | EP1827405A2 Capsaicinoid gel formulation and uses thereof |
| 09/05/2007 | EP1827404A2 Use of alpha-adrenergic blockers for the treatment of dysmenorrhea |
| 09/05/2007 | EP1827403A2 Compositions for treating surface ocular pathologies |
| 09/05/2007 | EP1827402A1 Oral formulations of desoxypeganine and uses thereof |
| 09/05/2007 | EP1827395A2 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles, their manufacturing and their use for diagnostics and therapy |
| 09/05/2007 | EP1827393A2 Room-temperature stable dronabinol formulations |
| 09/05/2007 | EP1827386A2 Oral compositions for absorption of phosphorus compounds |
| 09/05/2007 | EP1827385A2 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
| 09/05/2007 | EP1827384A1 Directly pressed indapamide tablets with delayed release of the active substance |
| 09/05/2007 | EP1827383A1 Pharmaceutical formulation comprising low crystallinity cellulose |
| 09/05/2007 | EP1827380A2 Coated drug delivery formulations |
| 09/05/2007 | EP1827379A2 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 09/05/2007 | EP1827376A1 Visco-supplement composition and methods |
| 09/05/2007 | EP1827374A2 Injectable nanoparticulate olanzapine formulations |
| 09/05/2007 | EP1827373A2 Ophthalmic emulsions containing prostaglandins |
| 09/05/2007 | EP1827298A2 Therapeutic adjuncts to enhance the organ protective effects of postconditioning |
| 09/05/2007 | EP1827104A2 Methods for promoting oral health in animals |
| 09/05/2007 | EP1827101A2 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 09/05/2007 | EP1730286A4 Therapeutic anti-cancer dna |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | EP1684749B1 USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 09/05/2007 | EP1633715B1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| 09/05/2007 | EP1628658A4 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 09/05/2007 | EP1626709B1 Enantiomeric amphetamine compositions for the treatment of adhd |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1613332B1 Use of gangliosides for mediating inflammation |
| 09/05/2007 | EP1578998A4 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use |
| 09/05/2007 | EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/05/2007 | EP1567490A4 Anti-sickling agents |
| 09/05/2007 | EP1562570A4 Treatment of amyotrophic lateral sclerosis with nimesulide |
| 09/05/2007 | EP1556054A4 Antagonizing nk1 receptors inhibits consumption of substances of abuse |
| 09/05/2007 | EP1545564B1 Combination preparation of hyaluronic acid and lidocaine and the use thereof |
| 09/05/2007 | EP1505967A4 Method for treating obesity |
| 09/05/2007 | EP1492796B1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 09/05/2007 | EP1487811B1 N-sulfonylurea apoptosis promoters |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1463733B1 Mitotic kinesin inhibitors |
| 09/05/2007 | EP1458391B1 A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1417955B1 Humectant and cosmetics and external preparations containing the same |
| 09/05/2007 | EP1406892B1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1345598B1 The use of rosiglitazone for treating psychiatric disorders. |
| 09/05/2007 | EP1336611B1 Dehalogeno compounds |
| 09/05/2007 | EP1265841A4 Process for the preparation of sodium salts of statins |
| 09/05/2007 | EP1257551B1 Heterocyclic compounds and their use as parp inhibitors |
| 09/05/2007 | EP1189621B1 Unfermented gel fraction from psyllium seed husks |
| 09/05/2007 | EP1113806B1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 09/05/2007 | EP1057815B1 Cyclic amide compounds |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN200942144Y Intrauterine device |
| 09/05/2007 | CN101031638A Use of dendrimers to stimulate cell growth |
| 09/05/2007 | CN101031589A Spray composition having a deposition control agent |
| 09/05/2007 | CN101031580A Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 09/05/2007 | CN101031572A (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 09/05/2007 | CN101031570A Inhibitors of vegf receptor and hgf receptor signaling |
| 09/05/2007 | CN101031569A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031566A Proline derivatives |
| 09/05/2007 | CN101031565A Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 09/05/2007 | CN101031564A Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 09/05/2007 | CN101031563A Benzimidazole derivatives, composition containing thereof and its preparation and application |